HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Pharmaceutical Research & Development
The pharmaceutical sector is involved in all phases of R&D, but it contributes the most to translating and applying knowledge to product development. Industry pays for the majority of the clinical trials required for market authorization. Research and development are one of the most significant aspects of the pharmaceutical industry. The pharmaceutical industry invests heavily on research and development. Higher drug prices can both cause and result in rising R&D expenses, as payer approval of higher pricing can make increasingly costly R&D and acquisitions of R&D projects financially viable. Increased R&D and acquisition expenditures might lead to price increases.
- Industrial and Physical Pharmacy
- Pharmaceutical Chemistry
- Advances in Pharmacological Research
- Pharmaceutical Organic Chemistry
- Clinical Research & Clinical Trials in Drug Delivery Systems
Committee Members
John K Maesaka
NYU Langone Hospital Long Island, United States
Consolato M Sergi
University of Ottawa, Canada
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Bernd Blobel
University of Regensburg, GermanySubmit your abstract Today
Title : Liver biopsy handling of Metabolic-Associated Fatty Liver Disease (MAFLD): The children's hospital of eastern Ontario grossing protocol
Consolato M Sergi, University of Ottawa, Canada
Title : Haptoglobin-Related Protein Without Signal Peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States
Title : Revolutionizing healthcare and pharma: Artificial intelligence-powered scientific communications and medical writing
Alessandro Gallo, Springer Healthcare, Italy
Title : Enabling knowledge-driven integration and interoperability in intelligent and ethical transformed health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up via biodesign-driven biotech and upgraded biomarketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Integration of nanotechnology into complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Combating aluminium chloride-induced alzheimer's in rats: Neuroprotective effects of Nelumbo nucifera and Bergenia ligulate
Nilay Solanki, Ramanbhai Patel College of Pharmacy, India
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, East Tennessee State University, United States
Title : Ayurvedic bhasmas as a nano medicines for the human kind
Prashant Sakharam Bhokardankar, Datta Meghe Ayurved College, Hospital & Research Centre, India